Overview Financials News + Filings IR Vault Key Docs Charts Transactions Holdings Ownership Insiders
|
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Revenues |
PEMAZYRE Royalty Revenues | 1.2 | | | | | | | |
OPZELURA | 128.7 | 4.7 | | | | | | |
United States | 3,200.0 | 2,900.0 | 2,600.0 | | | | | |
MINJUVI | 19.7 | 4.9 | | | | | | |
JAKAVI Royalty Revenues | 331.6 | 338.0 | 277.9 | 225.9 | 194.7 | 151.7 | | |
PEMAZYRE | 83.4 | 68.5 | 25.9 | 90.0 | | | | |
TABRECTA Royalty Revenues | 15.4 | 10.4 | 4.1 | | | | | |
|
EBIT |
United States | 766.8 | 991.9 | -16.6 | | | | | |
|
Mix |
PEMAZYRE Royalty Revenues | 0.0% | | | | | | | |
OPZELURA | 3.8% | 0.2% | | | | | | |
United States | 94.3% | 97.1% | 97.5% | | | | | |
MINJUVI | 0.6% | 0.2% | | | | | | |
JAKAVI Royalty Revenues | 9.8% | 11.3% | 10.4% | 10.5% | 10.3% | 9.9% | | |
PEMAZYRE | 2.5% | 2.3% | 1.0% | 4.2% | | | | |
TABRECTA Royalty Revenues | 0.5% | 0.3% | 0.2% | | | | | |
|
Growth |
OPZELURA | 2657.8% | | | | | | | |
United States | 10.3% | 11.5% | | | | | | |
MINJUVI | 300.3% | | | | | | | |
JAKAVI Royalty Revenues | -1.9% | 21.6% | 23.0% | 16.0% | 28.4% | | | |
PEMAZYRE | 21.8% | 164.8% | -71.2% | | | | | |
TABRECTA Royalty Revenues | 48.3% | 150.7% | | | | | | |
|